NATURE REVIEWS DRUG DISCOVERY

NATURE REVIEWS DRUG DISCOVERY(英文缩写 NAT REV DRUG DISCOV),ISSN 1474-1776,eISSN 1474-1784 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

NATURE REVIEWS DRUG DISCOVERY 最新收录文献

1. Perspectives on NMR in drug discovery: a technique comes of age.
   Maurizio Pellecchia, Ivano Bertini, David Cowburn, Claudio Dalvit, Ernest Giralt, Wolfgang Jahnke
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172689

   In the past decade, the potential of harnessing the ability of nuclear magnetic resonance (NMR) spectroscopy to monitor intermolecular interactions as a tool for drug discovery has been increasingly a…

   查看详情 DOI
2. Alvimopan.
   Conor P Delaney, Uma Yasothan, Peter Kirkpatrick
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172688
   查看详情 DOI
3. Osteoporosis: overview and pipeline.
   Uma Yasothan, Santwana Kar
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172687
   查看详情 DOI
4. An audience with...Frank Torti.
   Frank Torti
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172686
   查看详情 DOI
5. Industry concern over EU hepatotoxicity guidance.
   Bethan Hughes
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172685
   查看详情 DOI
6. Mixed results for disease-modification strategies for Alzheimer's disease.
   Alisa Opar
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172684
   查看详情 DOI
7. 60 years studying heart-disease risk.
   Daniel Levy
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 19172683
   查看详情 DOI
8. Nanoparticle therapeutics: an emerging treatment modality for cancer.
   Mark E Davis, Zhuo Georgia Chen, Dong M Shin
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 18758474

   Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while…

   查看详情 DOI
9. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.
   György Haskó, Joel Linden, Bruce Cronstein, Pál Pacher
   Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 18758473

   Adenosine is a key endogenous molecule that regulates tissue function by activating four G-protein-coupled adenosine receptors: A1, A2A, A2B and A3. Cells of the immune system express these receptors …

   查看详情 DOI
10. Targeting of tetraspanin proteins--potential benefits and strategies.
    Martin E Hemler
    Nature reviews. Drug discovery 2008 IF: 91.20 Q1 PMID: 18758472

    The tetraspanin transmembrane proteins have emerged as key players in malignancy, the immune system, during fertilization and infectious disease processes. Tetraspanins engage in a wide range of speci…

    查看详情 DOI